• The work of the Epidemiology of Bacterial Infections research group of IDIBELL and HUB indicates that the bacteria could achieve the resistance through the acquisition of mobile DNA fragments.
  • These fragments would contain the genes that confer resistance to antibiotics to this bacteria that causes multiple diseases.
  • H. parainfluenzae would have the ability to adapt to the environment since only strains isolated from the urogenital tract present the protective polysaccharide capsule, considered a virulence factor.

Haemophilus parainfluenzae is an opportunistic bacteria, which means that it can live in the host without causing problems. But in certain circumstances, when, for example, the immune system is weak, it can cause serious diseases that can even be life-threatening.

Antibiotic resistance is a natural phenomenon in which bacteria adapt and evolve to become resistant to antibiotic treatment. However, the misuse of these drugs in people and animals accelerates the process, making it one of the biggest public health problems worldwide.

In the case of H. parainfluenzae, the acquisition of resistance can occur through punctual mutations in the genome or by the addition of new genes that confer resistance. This second mechanism takes place thanks to the existence of small DNA fragments, called transposons, with the ability to move self-sufficiently, a common mechanism in many bacterial species.

The research group in Epidemiology of Bacterial Infections of the Bellvitge Biomedical Research Institute (IDIBELL) and the Bellvitge University Hospital (HUB), led by Dr. Sara Martí together with Dr. Carmen Ardanuy, have carried out a genomic study to characterize in detail the mechanisms of acquisition of resistance of H. parainfluenzae isolated from the urogenital and respiratory tracts. This study has been part of two doctoral theses that were defended at the Bellvitge campus last July by two members of the microbiology service, Yanik Sierra and Aida González.

The results, published in the Journal of Antimicrobial Chemotherapy, have identified large mobile DNA fragments that contain up to three transposons that confer resistance to different antibiotics. This, according to Dr. Martí, indicates that “the transferable elements could be playing a very important role in the transmission of resistance”, and adds, “these elements could contribute to the spread of this resistance from some bacteria to others“.

Recent studies of the same group had reported that strains of H. parainfluenzae isolated from the urogenital tract, and resistant to various antibiotics, had developed polysaccharide capsules, a characteristic not described so far in this bacterial species. “These envelopes composed of sugars are considered a virulence factor since they protect bacteria from attack by the immune system and other aggressions,” says Dr. Ardanuy.

The genomic analyzes carried out in the current study have only found the coding genes for the capsule in those strains isolated from the urogenital tract, which according to Drs. Martí and Ardanuy, could indicate the ability of H. parainfluenzae to adapt to different environments.

The Bellvitge Biomedical Research Institute (IDIBELL) is a biomedical research center created in 2004. It is participated by the Bellvitge University Hospital and the Viladecans Hospital of the Catalan Institute of Health, the Catalan Institute of Oncology, the University of Barcelona and the City Council of L’Hospitalet de Llobregat.

IDIBELL is a member of the Campus of International Excellence of the University of Barcelona HUBc and is part of the CERCA institution of the Generalitat de Catalunya. In 2009 it became one of the first five Spanish research centers accredited as a health research institute by the Carlos III Health Institute. In addition, it is part of the “HR Excellence in Research” program of the European Union and is a member of EATRIS and REGIC. Since 2018, IDIBELL has been an Accredited Center of the AECC Scientific Foundation (FCAECC).

Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

Apposite Capital refuerza su apuesta por...

by NIMGenetics

La firma británica se convierte en accionista mayoritario de la empre...

Photos Stream